Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase III Clinical Programme
Ann Rheum Dis 2020 DOI:10.1136/annrheumdis-2020-218510
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis 2020 DOI:10.1136/annrheumdis-2020-218510
Annals of the Rheumatic Diseases 2020;79:760-770
Annals of the Rheumatic Diseases 2020;79:778-786
Lancet Rheumatol 2020;2:e347–57
Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655.
Arthritis Rheumatol .2019 Sep;71(9):1450-1459. doi: 10.1002/art.40911. Epub 2019 Aug 6.
Arthritis Care Res (Hoboken) 2019;71(10):1387–95
Ann Rheum Dis. 2019 Aug;78(8):1048-1054.
Arthritis Res Ther. 2019 Apr 5;21(1):89.
Lipids Health Dis. 2019 Feb 18;18(1):54.